Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 3 Trials for Cabazitaxel (DB06772)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02961257Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a DocetaxelTreatment